2 weeks Ago By Defense World Staff
Invesco Ltd. purchased a new stake in Alpha Teknova, Inc. ( NASDAQ:TKNO – Free Report ) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
The firm purchased 1,106,161 shares of the company’s stock, valued at approximately $9,236,000. Invesco Ltd. owned approximately 2.
07% of Alpha Teknova as of its most recent filing with the Securities and Exchange Commission. A number of other hedge funds have also added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its holdings in shares of Alpha Teknova by 24.
4% in the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after purchasing an additional 36,914 shares in the last quarter. Raymond James Financial Inc.
purchased a new stake in Alpha Teknova in the 4th quarter valued at $716,000. State Street Corp lifted its stake in Alpha Teknova by 249.3% during the 3rd quarter.
State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after acquiring an additional 54,700 shares in the last quarter. Nkcfo LLC purchased a new position in Alpha Teknova during the 4th quarter worth $501,000. Finally, Tradewinds LLC.
bought a new stake in shares of Alpha Teknova in the 4th quarter worth $383,000. Institutional investors and hedge funds own 13.81% of the company’s stock.
Analyst Ratings Changes Separately, Craig Hallum began coverage on shares of Alpha Teknova in a research note on Monday, February 10th. They set a “buy” rating and a $12.00 price target for the company.
Alpha Teknova Stock Up 4.0 % Shares of NASDAQ:TKNO opened at $6.43 on Thursday.
The firm has a market capitalization of $343.60 million, a P/E ratio of -8.69 and a beta of 0.
54. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.
94 and a current ratio of 4.73. Alpha Teknova, Inc.
has a 52-week low of $1.16 and a 52-week high of $10.37.
The stock has a 50 day moving average price of $5.92 and a 200-day moving average price of $7.05.
Alpha Teknova ( NASDAQ:TKNO – Get Free Report ) last announced its earnings results on Tuesday, March 4th. The company reported ($0.11) EPS for the quarter.
The business had revenue of $9.27 million for the quarter, compared to analysts’ expectations of $9.10 million.
Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%.
As a group, equities research analysts anticipate that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.
About Alpha Teknova ( Free Report ) Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. Recommended Stories Five stocks we like better than Alpha Teknova Most active stocks: Dollar volume vs share volume Can IBM’s Q1 Earnings Spark a Breakout for the Stock? What Are Dividends? Buy the Best Dividend Stocks S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry? 2 Fintech Stocks to Buy Now and 1 to Avoid Fundamentally Sound, These 5 Stocks Sold Off Anyway Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.
com's FREE daily email newsletter ..
